Clinical Trial Update: Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety trial evaluating weekly infusions of BB-10901 in patients with Small Cell Lung Cancer has been completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BB-10901

Snippet

Sponsor: ImmunoGen, Inc. | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-06-20